These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37225533)
1. Prognostic Value of Inflammation Biomarkers in Penile Squamous Cell Carcinoma Patients Without Distant Metastasis. Xue T; Li ZS; Wu C; Li YH; Liu ZW; Qin ZK; Yao K; Zhou FJ; Han H Clin Genitourin Cancer; 2023 Oct; 21(5):e334-e342.e1. PubMed ID: 37225533 [TBL] [Abstract][Full Text] [Related]
2. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695 [TBL] [Abstract][Full Text] [Related]
5. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the high-sensitivity modified glasgow prognostic score on patients undergoing radical surgery for hepatocellular carcinoma : Authorship. Luo B; Zhang Y; Zhu X; Ji T; Wu K; Sun D; Lu Y; Shi L Langenbecks Arch Surg; 2024 Jul; 409(1):223. PubMed ID: 39023651 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078 [TBL] [Abstract][Full Text] [Related]
8. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
9. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer. Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma. Zheng C; Liu S; Feng J; Zhao X Cancer Manag Res; 2020; 12():2415-2425. PubMed ID: 32280277 [TBL] [Abstract][Full Text] [Related]
11. A Clinical Nomogram for Predicting Overall Survival in Patients With T1/T2 Penile Squamous Cell Carcinoma. Qian S; Liu C; Zhao Y; Jin H; Li X; Zhao X Clin Genitourin Cancer; 2024 Oct; 22(5):102114. PubMed ID: 38959838 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of HPV-associated and HPV-independent penile squamous cell carcinoma prognostic nomogram. Liu S; Shen Z; Yang H; Wang J; Wang X; Gong Y; Liu S; Lu Z; Huang T Int Urol Nephrol; 2024 Sep; 56(9):2929-2944. PubMed ID: 38679654 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma. Feng J; Wang L; Wang L; Yang X; Lou G BMC Cancer; 2022 Mar; 22(1):284. PubMed ID: 35300627 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
15. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy. Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854 [TBL] [Abstract][Full Text] [Related]
16. Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score. Draeger DL; Groh S; Buchholz T; Woehl M; Nolting J; Hakenberg OW Urol Int; 2023; 107(5):489-495. PubMed ID: 34610603 [TBL] [Abstract][Full Text] [Related]
17. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541 [TBL] [Abstract][Full Text] [Related]
18. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy]. Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218 [No Abstract] [Full Text] [Related]
19. Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis. Cui C; Wu X; Deng L; Wang W; Cui W; Wang Y Thorac Cancer; 2022 Jul; 13(14):2041-2049. PubMed ID: 35624549 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study. Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW Front Oncol; 2022; 12():825967. PubMed ID: 35242712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]